You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
15 January 2013 - 15 January 2013 - US Boehringer Ingelheim Pharmaceuticals Inc, part of German Boehringer Ingelheim Corp, said today that the US Food and Drug Administration (FDA) had given a priority review to its New Drug Application (NDA) for the...
15 January 2013 - 15 January 2013 - Israeli Pluristem Therapeutics (NASDAQ:PSTI) said today it had received the approval of Germany’s Paul-Ehrlich-Institute to start a Phase II study using PLX-PAD cells in patients living with intermittent clau...
14 January 2013 - Janssen-Cilag International NV (Janssen) announced on Friday the approval by the European Commission (EC) of an extension to the license of the oral, once-daily medication ZYTIGA (abiraterone acetate).
This approved broader indicat...
14 January 2013 - Global healthcare company Merck & Co Inc (NYSE:MRK) (MSD outside US and Canada) announced on Friday that it is taking steps to suspend the availability of TREDAPTIVE (nicotinic acid/laropiprant, MSD) modified-release tablets worldwi...
14 January 2013 - GeoVax Labs, an Atlanta-based vaccine developer, has completed the enrolment of nine patients in a Phase 1/2 trial evaluating the safety, immunogenicity and ability of its DNA/MVA vaccine, the HIV/AIDS therapeutic vaccine, it was re...
14 January 2013 - Celerion, a clinical research company, has added a bronchoscopy suite at its Belfast, Northern Ireland, United Kingdom plant.
It is reported today that the bronchoscopy suite has been added to expand the company’s respiratory...
14 January 2013 - 14 January 2013 - Norwegian Algeta ASA (OSL:ALGETA) said today the US Nuclear Regulatory Commission (NRC) had authorised the use of radium-223 dichloride (radium-223) after the prostate cancer drug candidate was recommended by the A...